Uncategorized

Novo Nordisk Stock Crashes More Than 20% After Disappointing Obesity Drug Data. Eli Lilly Shares Soar. – Barron’s

Posted on Author Comments Off on Novo Nordisk Stock Crashes More Than 20% After Disappointing Obesity Drug Data. Eli Lilly Shares Soar. – Barron’s
  1. Novo Nordisk Stock Crashes More Than 20% After Disappointing Obesity Drug Data. Eli Lilly Shares Soar.  Barron’s
  2. Novo Nordisk shares plunge 20% after disappointing trial results; Lilly jumps  CNBC
  3. Novo Nordisk stock sees biggest loss in more than 20 years on CagriSema results  Yahoo Finance
  4. Novo Nordisk Shares Plunge After New Obesity Shot Disappoints  The Wall Street Journal
  5. Novo Nordisk Falls Most on Record After New Weight Drug Disappoints  Bloomberg